Sales & Marketing News | pharmaphorum

News

BMS lawsuit claims AZ's Imjudo infringes Yervoy patents

AstraZeneca followed a long and arduous road to bring its CTLA4 inhibitor Imjudo to market, and will now have to defend its new product from a patent infringement complaint brought by Brist

News

Lilly injects $450m into plant making Mounjaro

Eli Lilly is leaving nothing to chance when it comes to making the most of its fast-growing diabetes therapy Mounjaro – it is investing another $450million at a facility in North Carolina t

News

Amazon unveils $5 subscription service for generics

Efforts by Amazon to disrupt the healthcare sector just stepped up a gear, with the launch of a subscription service for Prime members that will ship generic medicines to patients' homes in

News

Call to arms as UK falls back in medicines manufacturing

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition.

News

Sandoz bulks up with Mycamine ahead of spin-off

With a separation from parent company Novartis now confirmed, Sandoz has moved to strengthen its revenue base with the acquisition of global rights to mainstay antifungal drug Mycamine from

News

Takeda grabs ex-China fruquintinib rights from Hutchmed

Chinese biotech Hutchmed's push to sign partnerships for its drug products outside its home market has resulted in a $1.13 billion deal with Japan's Takeda, including a hefty upfront fee of

BMS lawsuit claims AZ's Imjudo infringes Yervoy patents

Lilly injects $450m into plant making Mounjaro

Amazon unveils $5 subscription service for generics

Call to arms as UK falls back in medicines manufacturing

Sandoz bulks up with Mycamine ahead of spin-off

Takeda grabs ex-China fruquintinib rights from Hutchmed

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks